癌症中的神素激酶2:对其表达,功能和抑制剂发育的审查
Yanqun Luo1, Haiping Xue2, Ying Gao3
1Institute of Digestive Disease, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai 200032, China; Institute of Interdisciplinary Integrative Medicine Research, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China.
International journal of biological macromolecules
|February 23, 2025
概括
斯芬哥辛激酶2 (SphK2) 在癌症中起作用,但其功能尚未完全理解. 这篇评论详细介绍了SphK2的细节.
科学领域:
- 在瘤学瘤学.
- 利皮多米克 (Lipidomics) 是一种消化剂.
- 生物化学 生物化学
背景情况:
- 癌症仍然是一个重大的全球健康挑战,治疗需求尚未得到满足.
- 脂质组学研究强调了脂质代谢在癌症中的关键作用.
- 脂代谢,涉及氨酸激酶 (SphK) 和氨酸-1-酸盐 (S1P),对于细胞功能至关重要.
研究的目的:
- 综合审查各种癌症中斯芬哥辛激酶2 (SphK2) 的表达,分布和机制.
- 探索SphK2抑制剂研究对潜在癌症治疗的当前进展.
- 阐明SphK2在瘤发生中的多方面的作用,为未来的瘤学研究和治疗应用提供见解.
主要方法:
- 对SphK2表达和癌症中的功能现有文献的回顾性分析.
- 详细介绍SphK2在致癌过程中的分子机制的研究.
- 关于SphK2抑制剂设计和评估的最新进展的调查.
主要成果:
- SphK2在广泛的人类癌症中表达,这表明它在瘤发生过程中发挥了广泛的作用.
- SphK2的精确致癌功能复杂且取决于环境,与其异型SphK1.1不同.
- 新兴的SphK2抑制剂显示出希望,但它们的临床疗效需要进一步研究.
结论:
- 在癌症的发展和进展中,SphK2是一个重要的,但尚未研究的参与者.
- 对于新的癌症治疗策略,需要对SphK2的特定作用和有针对性的抑制进行进一步的研究.
- 了解SphK2对瘤发生的贡献,可能会为瘤学开辟新的治疗途径.
相关概念视频
Inhibition of Cdk Activity
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
Cancer-Critical Genes II: Tumor Suppressor Genes
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Inhibition of CDK Activity
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Cancer-Critical Genes II: Tumor Suppressor Genes
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...


